Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab +/- Lenalidomide plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2022)
关键词
ABCL, tafasitamab, lenalidomide, DLBCL, First-MIND, pharmacokinetics, Phase I
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要